In contemporary medicine, a significant discovery has been made regarding the profound interconnection between chronic diseases prevalent in modern society, including obesity, diabetes, kidney disease, and heart disease. These conditions are no longer viewed as isolated ailments but as a deeply linked systemic progression known as CKM Syndrome (Cardiovascular – Kidney – Metabolic Syndrome). This syndrome represents a silent threat that significantly impacts the health of people today.
What is CKM Syndrome?
CKM Syndrome refers to a group of abnormalities involving three major systems in the body:
- Cardiovascular System: This includes coronary artery disease, heart failure, and stroke.
- Kidney System: Specifically chronic kidney disease, which impairs the body’s ability to filter waste and maintain the balance of water and minerals.
- Metabolic System: The body’s metabolic processes, including conditions such as abdominal obesity, diabetes, high blood pressure, and high cholesterol.
The progression often begins with seemingly minor issues, such as excess abdominal fat. This lead to low – level chronic inflammation and insulin resistance, creating a vicious cycle that progressively damages the blood vessels, kidneys, and heart.
The Dangerous Cycle of Organ Damage
The most concerning aspect of CKM Syndrome is that organs can be significantly damaged even when a patient remains asymptomatic. The connections between these systems function as follows:
- From Metabolic to Heart: Chronic high blood sugar from diabetes damages blood vessel walls, causing them to stiffen and narrow, which increases the risk of heart attacks.
- From High Blood Pressure to Kidney: Uncontrolled blood pressure destroys the small capillaries in the kidneys, accelerating kidney deterioration.
- From Kidney to Heart: When kidneys fail to effectively excrete water or waste, the heart must work significantly harder to pump blood, which can lead to acute heart failure.
- From Lipids to the Entire System: High blood lipids (cholesterol) accumulate on vessel walls throughout the body—including the heart, brain, and kidneys—leading to blockages and inflammation.
Stages of CKM Syndrome and Management Guidelines
The American Heart Association (AHA) categorizes the severity of CKM Syndrome into five stages (Stage 0–4) to facilitate appropriate prevention and treatment planning.
|
Stage |
Condition Characteristics |
Management and Prevention Guidelines |
|
Stage 0 |
No Risk: Heart, kidneys, and metabolism are functioning normally. |
Focus on primary prevention and maintaining healthy lifestyle habits for long-term health. |
|
Stage 1 |
Early Risk: Presence of abdominal obesity, being overweight, or prediabetes. |
Behavior modification to achieve at least 5 – 10% weight loss, diet control, and regular exercise. |
|
Stage 2 |
Metabolic/Kidney Risk: Type 2 diabetes, high blood pressure, high cholesterol, or early-stage kidney disease. |
Use medication to control blood pressure (<130/80 mmHg) and Statins for lipids. Consider heart and kidney – protective drugs like SGLT2 inhibitors or GLP – 1RAs. |
|
Stage 3 |
Silent Organ Damage: Asymptomatic damage such as protein in the urine or high coronary artery calcium (CAC Score 100 – 400). |
Intensify drug therapy to prevent cardiovascular disease, consider Aspirin for high-risk cases, and closely monitor heart and kidney function. |
|
Stage 4 |
Clinical Disease: Manifestation of heart failure, stroke, chronic kidney failure, or peripheral artery disease. |
Standardized medical therapy (GDMT), dialysis for kidney failure, and multidisciplinary care to reduce mortality rates. |
Who is at Risk?
Individuals who meet the following criteria should undergo a risk assessment for CKM Syndrome:
- Obesity or being overweight (BMI ≥ 25, or ≥ 23 for Asians).
- Abdominal obesity (waist circumference ≥ 90 cm for men, ≥ 80 cm for women).
- Diagnosis of diabetes or prediabetes.
- High blood pressure or high blood lipids.
- Chronic kidney disease.
- Fatty liver disease.
- Age 40 years or older.
- Family history of heart or kidney disease.
Proactive Treatment: A Continuum of Care
The core of treating CKM Syndrome in the modern era is not treating each disease in isolation, but providing a “Continuum of Care”—a comprehensive and seamless management strategy focusing on four main pillars:
- Behavioral Modification: This is the most critical foundation. It involves dietary control (reducing sugar, fat, and salt) and exercising for at least 150 minutes per week.
- Modern Pharmacotherapy (Multi-organ Protection): Physicians may consider new classes of medications that protect multiple systems simultaneously, such as drugs that excrete sugar via urine (reducing heart load and slowing kidney decay) or medications that simultaneously reduce weight and protect blood vessels.
- Regular Kidney Function Monitoring: Routine checks of the glomerular filtration rate (eGFR) and urine protein levels are essential, alongside avoiding medications that may damage the kidneys.
- Cardiovascular Prevention: Following medical advice for heart health screenings and maintaining strict control over lipid levels and blood pressure.
Expert Care for CKM Syndrome
The Internal Medicine Clinic at Bangkok Hospital provides comprehensive care for CKM Syndrome through a multidisciplinary team. This team includes cardiologists, nephrologists, and endocrinologists who collaborate to provide in-depth risk assessments, personalized treatment plans, and modern medical technologies. The goal is to control the disease, delay organ deterioration, and enhance long – term quality of life.
Do not wait for symptoms to appear;
CKM Syndrome is a silent threat that can be prevented if care begins today.
References:
- Ndumele CE, et al. A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association. Circulation. 2023.
